Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy
- PMID: 34059893
- DOI: 10.1093/brain/awab130
Tau mis-splicing correlates with motor impairments and striatal dysfunction in a model of tauopathy
Abstract
Tauopathies are neurodegenerative diseases caused by the abnormal metabolism of the microtubule associated protein tau (MAPT), which is highly expressed in neurons and critically involved in microtubule dynamics. In the adult human brain, the alternative splicing of exon 10 in MAPT pre-mRNA produces equal amounts of protein isoforms with either three (3R) or four (4R) microtubule binding domains. Imbalance in the 3R:4R tau ratio is associated with primary tauopathies that develop atypical parkinsonism, such as progressive supranuclear palsy and corticobasal degeneration. Yet, the development of effective therapies for those pathologies is an unmet goal. Here we report motor coordination impairments in the htau mouse model of tauopathy which harbour abnormal 3R:4R tau isoforms content, and in contrast to TauKO mice, are unresponsive to l-DOPA. Preclinical-PET imaging, array tomography and electrophysiological analyses indicated the dorsal striatum as the candidate structure mediating such phenotypes. Indeed, local modulation of tau isoforms by RNA trans-splicing in the striata of adult htau mice, prevented motor coordination deficits and restored basal neuronal firing. Together, these results suggest that abnormal striatal tau isoform content might lead to parkinsonian-like phenotypes and demonstrate a proof of concept that modulation of tau mis-splicing is a plausible disease-modifying therapy for some primary tauopathies.
Keywords: RNA therapy; microPET; parkinsonism; tau; tauopathies.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
SMaRT modulation of tau isoforms rescues cognitive and motor impairments in a preclinical model of tauopathy.Front Bioeng Biotechnol. 2022 Oct 5;10:951384. doi: 10.3389/fbioe.2022.951384. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36277399 Free PMC article.
-
Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy.Cell Rep. 2018 Apr 17;23(3):709-715. doi: 10.1016/j.celrep.2018.03.079. Cell Rep. 2018. PMID: 29669277
-
Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.Brain. 2022 Mar 29;145(1):349-361. doi: 10.1093/brain/awab289. Brain. 2022. PMID: 34515757
-
The Role of Tau Proteoforms in Health and Disease.Mol Neurobiol. 2023 Sep;60(9):5155-5166. doi: 10.1007/s12035-023-03387-8. Epub 2023 Jun 2. Mol Neurobiol. 2023. PMID: 37266762 Review.
-
Regulation of alternative splicing of tau exon 10.Neurosci Bull. 2014 Apr;30(2):367-77. doi: 10.1007/s12264-013-1411-2. Epub 2014 Mar 14. Neurosci Bull. 2014. PMID: 24627328 Free PMC article. Review.
Cited by
-
SMaRT modulation of tau isoforms rescues cognitive and motor impairments in a preclinical model of tauopathy.Front Bioeng Biotechnol. 2022 Oct 5;10:951384. doi: 10.3389/fbioe.2022.951384. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36277399 Free PMC article.
-
Tau reduction with artificial microRNAs modulates neuronal physiology and improves tauopathy phenotypes in mice.Mol Ther. 2024 Apr 3;32(4):1080-1095. doi: 10.1016/j.ymthe.2024.01.033. Epub 2024 Feb 3. Mol Ther. 2024. PMID: 38310353
-
Tauopathies: new perspectives and challenges.Mol Neurodegener. 2022 Apr 7;17(1):28. doi: 10.1186/s13024-022-00533-z. Mol Neurodegener. 2022. PMID: 35392986 Free PMC article. Review.
-
Does the Anti-Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? Yes.Mov Disord Clin Pract. 2021 Aug 31;8(7):1034-1037. doi: 10.1002/mdc3.13324. eCollection 2021 Oct. Mov Disord Clin Pract. 2021. PMID: 34631938 Free PMC article. No abstract available.
-
High altitude is associated with pTau deposition, neuroinflammation, and myelin loss.Sci Rep. 2022 Apr 27;12(1):6839. doi: 10.1038/s41598-022-10881-x. Sci Rep. 2022. PMID: 35477957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources